Rarity of large vessel disease in African diabetics--the role of anti-thrombin IIi
Onyemelukwe, G.C.; Mba, E.C.
East African Medical Journal 65(3): 160-164
1988
ISSN/ISBN: 0012-835X PMID: 3265098 Document Number: 308583
Document emailed within 1 workday
Related Documents
Momi, S.; Nasimi, M.; Colucci, M.; Nenci, G.G.; Gresele, P. 2001: Low molecular weight heparins prevent thrombin-induced thrombo-embolism in mice despite low anti-thrombin activity. Evidence that the inhibition of feed-back activation of thrombin generation confers safety advantages over direct thrombin inhibition Haematologica 86(3): 297-302Schirmer, M.; Calamia, K.T.; O'Duffy, J.D. 1999: Is there a place for large vessel disease in the diagnostic criteria of Behçet's disease? Journal of Rheumatology 26(12): 2511-2512
Ferro, J.M.; Salgado, A.V.; Oliveira, V. 1995: Lacunar stroke associated headache is not related to intracranial large vessel disease Revista de Neurologia 23(122): 741-742
Takahashi, W. 2006: Association between intra- and extra-cranial large vessel disease in atherothrombotic infarction Nihon Rinsho. Japanese Journal of Clinical Medicine 64 Suppl. 8: 116-119
Jervell, J. 1976: Oral anti-diabetics--dangerous drugs for diabetics? Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 96(22): 1149
Sergeev, I.I.; Bashkov, G.V. 1997: Direction of the vasomotor effects of thrombin is regulated by the vessel tonus Biulleten' Eksperimental'noi Biologii i Meditsiny 123(4): 367-369
Henry, M.L.; Ketel, B.L.; Elkhammas, E.A.; Tesi, R.J.; Ferguson, R.M. 1990: The role of transplantation in diabetics with end-stage renal disease Clinical Transplants 1990: 203-215
Mundo-Sagardía, J.; Altieri, P.; Banch, H.; González, R.; Escobales, N.; Crespo, M.; Rodríguez-Orengo, J.; Cardona, F.; Torrado, J. 2003: Role of endothelin i and angiotensin Ii in type 2 diabetics with coronary disease Boletin de la Asociacion Medica de Puerto Rico 95(5): 45-50
Di Domenico, M.R.; Annaluisa, S.; Pluvio, R.; Iovine, C.; Rea, F. 2002: The role of anti-endomysium and anti-transglutaminase antibodies in the diagnosis and follow-up of celiac disease La Pediatria Medica e Chirurgica: Medical and Surgical Pediatrics 24(3): 208-212
Andersch, H.; Arzberger, H.; Köhler, W. 1970: Ankylosing hyperostosis of the spine (Forestier's disease) in diabetics. Systematic x-ray examinations of 1,000 diabetics Das Deutsche Gesundheitswesen 25(42): 1991-1994
Bruhn, H.D. 1981: Growth regulation of vessel wall cells and of tumor cells by thrombin, factor XIIi and fibronectin Thrombosis and Haemostasis 46(4): 762
Bruneval, P.; Fiessinger, J.N. 1999: Large vessel vasculitides Annales de Pathologie 19(3): 223-237
Schlumpf, U. 1978: The effect of diclofenac sodium on the metabolism of diabetics in qualitative diet therapy with an without tolbuamide. a clinically oriented study in aged diabetics with rheumatic disease Schweizerische Medizinische Wochenschrift 108(1): 28-34
Rehák, Z.; Fojtík, Z.; Stanícek, J.; Bolcák, K.; Frysáková, L. 2006: 18F-FDG PET in the diagnosis of large vessel vasculitis Vnitrni Lekarstvi 52(11): 1037-1044
Losev, A.K. 1973: Case of an atypical large vessel of the lung Vestnik Rentgenologii i Radiologii 48(4): 80-81
Xia, W.K. 1988: Leiomyosarcoma in the musculature of large vessel wall Zhonghua Zhong Liu Za Zhi 10(2): 155-156
Astrup, J.; Voldby, B. 1992: Radiotherapy has no effect on large vessel abnormalities in the brain Ugeskrift for Laeger 154(52): 3768
Monti, S.; Águeda, A.F.; Luqmani, R. 2018: The use of ultrasound in the management of large-vessel vasculitis: an evolving concept Clinical and Experimental Rheumatology 36 Suppl 114(5): 96-102
Sadrkhah, A.; Seebach, J.ör.D.; Muller, Y. 2017: Large vessel vasculitis : pathogenesis, diagnostic and medical management Revue Medicale Suisse 13(557): 758-762
Spies, C.M.; Burmester, G.-R.; Buttgereit, F. 2010: Methotrexate treatment in large vessel vasculitis and polymyalgia rheumatica Clinical and Experimental Rheumatology 28(5 Suppl 61: S172-S177